CGuard Carotid Embolic Protection Device Trial Will be Led by Chris Metzger
InspireMD s MicroNet embolic protection mesh on stents is designed to prevent emboli during carotid stenting.
February 9, 2021 InspireMD Inc., developer of the CGuard Embolic Prevention System (EPS) for the prevention of stroke caused by carotid artery disease, announced the appointment of Chris Metzger, M.D., system chair of clinical research at Ballad Health System in Eastern Tennessee as the principal investigator for its planned U.S. FDA registration trial for CGuard EPS.
This upcoming trial will investigate the safety and efficacy of InspireMD s MicroNet embolic protection system technology for carotid stenting. It is designed to prevent stroke during stent placement and help improve long-term outcomes.